成人胶质母细胞瘤诊疗差异:综合叙述性综述
该叙述性综述综合流行病学、卫生系统研究与定性研究,审视成人胶质母细胞瘤在 socioeconomic status、种族 ethnicity、地理位置、医疗基础设施及机构特征等轴向上的诊疗差异。差异不仅见于低资源地区和中低收入国家,也存在于高收入国家及全民医疗体系中,社会人口学变量持续影响接受指南一致治疗的可能性。差异多为系统性且可干预,患者导航、区域化策略、包容性临床试验框架及政策改革提供可行路径。
要点
- 胶质母细胞瘤诊疗差异沿社会经济地位、种族 ethnicity、地理位置等多轴线存在。
- 差异在高收入国家和全民医疗体系内同样存在,影响指南一致治疗的可及性。
- 差异多为系统性且可干预,需贯穿神经肿瘤诊疗全流程的公平导向策略。
核心结论
- 成人胶质母细胞瘤诊疗差异在很大程度上由系统性因素驱动且可干预。
- 需要贯穿神经肿瘤诊疗全流程的协调、公平导向策略。
研究设计与样本
- 叙述性综述,综合流行病学研究、卫生系统研究与定性调查。
- 审视社会经济地位、种族 ethnicity、地理位置、医疗基础设施及机构特征等多轴差异。
主要发现
- 差异体现在诊断、治疗可及性、临床试验参与及临终关怀等多个环节。
- 差异不仅见于低资源环境和中低收入国家,也见于高收入国家与全民医疗体系。
- 社会人口学变量持续影响患者接受指南一致治疗的可能性。
关键数值与推荐
- 患者导航项目、区域化策略、包容性临床试验框架及政策层面改革被视为新兴干预路径。
临床怎么用
- 临床应识别社会人口学与结构性障碍对指南一致治疗可及性的影响。
- 可探索患者导航、区域化协作与包容性临床试验参与等公平导向措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glioblastoma is the most common and aggressive primary malignant brain tumor in adults. While tumor biology plays a central role in disease progression, a substantial and growing body of evidence implicates structural and social determinants of health in mediating access to care and influencing clinical outcomes. This narrative review critically examines disparities in glioblastoma care across multiple axes, including socioeconomic status, race and ethnicity, geographic location, healthcare infrastructure, and institutional characteristics. Findings are synthesized from epidemiologic studies, health systems research, and qualitative investigations to elucidate the mechanisms by which inequities in diagnosis, treatment access, clinical trial participation, and end-of-life care arise and persist. Disparities are evident not only in low-resource settings and low-/middle-income countries, but also within high-income nations and universal healthcare systems, where sociodemographic variables continue to influence the likelihood of receiving guideline-concordant care. Emerging interventions, such as patient navigation programs, regionalization strategies, inclusive clinical trial frameworks, and policy-level reforms, offer actionable pathways to mitigate these inequities. Our findings underscore that disparities in glioblastoma care are largely systemically driven and modifiable, necessitating coordinated, equity-oriented strategies across the continuum of neuro-oncologic care.
引用
- Davalan W, Alkins R. Disparities in Care in Adult Glioblastoma: A Comprehensive Narrative Review. World Neurosurg. 2026. PMID: 41997291. doi:10.1016/j.wneu.2026.124992
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。